OS Therapies (OSTX)
NYSE: OSTX
· Real-Time Price · USD
1.88
-0.02 (-1.05%)
At close: Jun 17, 2025, 1:49 PM
-1.05% (1D)
| Bid | 1.83 |
| Market Cap | 52.68M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -3.88B |
| EPS (ttm) | -0.99 |
| PE Ratio (ttm) | -1.89 |
| Forward PE | -16.55 |
| Analyst | Buy |
| Ask | 1.89 |
| Volume | 183,726 |
| Avg. Volume (20D) | 272,349 |
| Open | 1.85 |
| Previous Close | 1.90 |
| Day's Range | 1.82 - 1.93 |
| 52-Week Range | 1.12 - 7.00 |
| Beta | -5.55 |
About OSTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol OSTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for OSTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+13.53%
OS Therapies shares are trading higher after Lake ...
Unlock content with
Pro Subscription
4 months ago
+12.06%
OS Therapies shares are trading higher after the company announced agreements for the commercial manufacture of OST-HER2.
2 months ago · https://www.marketscreener.com
Investing in the $532B Oncology Boom: Key Stocks Shaping the Future of Cancer TreatmentThe global oncology drug market, valued at over $200 billion today, is on pace to reach $532 billion by 2031-a growth story driven not just by rising demand but by genuine innovation. After years of i...
